Kim C - Search Results

1

Metabolism and macrophages in the tumor microenvironment.

Yang H, Kim C, Zou W. Yang H, et al. Among authors: kim c. Curr Opin Immunol. 2024 Oct 4;91:102491. doi: 10.1016/j.coi.2024.102491. Online ahead of print. Curr Opin Immunol. 2024. PMID: 39368171 Review.

2

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma.

Yang H, Kang B, Ha Y, Lee SH, Kim I, Kim H, Lee WS, Kim G, Jung S, Rha SY, Gaillard VE, Cheon J, Kim C, Chon HJ. Yang H, et al. Among authors: kim h, kim g, kim c, kim i. JHEP Rep. 2023 Jan 16;5(4):100672. doi: 10.1016/j.jhepr.2023.100672. eCollection 2023 Apr. JHEP Rep. 2023. PMID: 36866388 Free PMC article.

3

High Levels of Antidrug Antibodies Against Atezolizumab as a Predictive Marker for Clinical Outcomes in Patients With Hepatocellular Carcinoma-Reply.

Kim C, Yang H, Chon HJ. Kim C, et al. JAMA Oncol. 2023 May 1;9(5):725-726. doi: 10.1001/jamaoncol.2023.0111. JAMA Oncol. 2023. PMID: 36928517 No abstract available.

4

High levels of baseline serum IL-10 are associated with reduced clinical benefit from first-line immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Kim Y, Yang H, Lee WS, Cheon J, Sang YB, Kang B, Chon HJ, Kim C. Kim Y, et al. Among authors: kim c. J Cancer. 2023 Apr 2;14(6):935-942. doi: 10.7150/jca.81384. eCollection 2023. J Cancer. 2023. PMID: 37151396 Free PMC article.

5

Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance.

Lin H, Tison K, Du Y, Kirchhoff P, Kim C, Wang W, Yang H, Pitter M, Yu J, Liao P, Zhou J, Vatan L, Grove S, Wei S, Vigil T, Shah YM, Mortensen R, Kryczek I, Garmire L, Sivaccumar JP, Ramesh AK, Zhang N, An Z, Wang S, Zou W. Lin H, et al. Among authors: kim c. Cancer Cell. 2024 Nov 1:S1535-6108(24)00398-2. doi: 10.1016/j.ccell.2024.10.010. Online ahead of print. Cancer Cell. 2024. PMID: 39515327 Free article.

6

Engagement of CD300c by a novel monoclonal antibody induces the differentiation of monocytes to M1 macrophages.

Lee SI, Kim H, Lim CK, Kim JD, Heo JS, Jung J, Kim C, Chon HJ, Jeon JW. Lee SI, et al. Among authors: kim h, kim c, kim jd. Immunobiology. 2024 Jan;229(1):152780. doi: 10.1016/j.imbio.2023.152780. Epub 2023 Dec 21. Immunobiology. 2024. PMID: 38159528 Free article.

7

Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer.

Hwang S, Woo S, Kang B, Kang H, Kim JS, Lee SH, Kwon CI, Kyung DS, Kim HP, Kim G, Kim C, Chon HJ. Hwang S, et al. Among authors: kim g, kim c, kim hp, kim js. J Hepatol. 2024 Oct 21:S0168-8278(24)02641-2. doi: 10.1016/j.jhep.2024.10.020. Online ahead of print. J Hepatol. 2024. PMID: 39442892 Free article.

8

ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.

Lee SH, Cheon J, Lee S, Kang B, Kim C, Shim HS, Park YN, Jung S, Choi SH, Choi HJ, Lee CK, Chon HJ. Lee SH, et al. Among authors: kim c. Cancer Res Treat. 2023 Oct;55(4):1291-1302. doi: 10.4143/crt.2022.1450. Epub 2023 May 3. Cancer Res Treat. 2023. PMID: 37139666 Free PMC article.

9

"Pikachu-shaped" flap for extramammary Paget's disease.

Kim CW, Park TH. Kim CW, et al. Int Wound J. 2019 Apr;16(2):576-578. doi: 10.1111/iwj.13040. Epub 2018 Nov 15. Int Wound J. 2019. PMID: 30440107 Free PMC article. No abstract available.

10

Customized reconstruction with modified keystone flaps.

Lee JW, Kim CW, Park TH. Lee JW, et al. J Dermatol. 2018 Jul;45(7):844-849. doi: 10.1111/1346-8138.14356. Epub 2018 May 9. J Dermatol. 2018. PMID: 29740873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,188 results

Search Page

Filters